%0 Journal Article
%T Evidence for treatment with anti-PD-1 antibody for thymic cancer: how to identify patients most likely to benefit
%A Suina, Kentaro
%A Shukuya, Takehito
%J Shanghai Chest
%D 2019
%B 2019
%9 
%! Evidence for treatment with anti-PD-1 antibody for thymic cancer: how to identify patients most likely to benefit
%K 
%X Thymic epithelial tumor (TET) is a rare disease with an annual incidence of 0.15 cases per 100,000 people (1). Accordingly, thymic carcinoma (TC) accounts for approximately 14% of all such cases (2). However, developing treatments for TC is fraught with many practical challenges, whereas critical medical needs remain unmet.
%U https://shc.amegroups.org/article/view/5516
%V 3
%P 
%@ 2521-3768